Figure 3
From: Immunomodulatory strategies prevent the development of autoimmune emphysema
Immunostaining for B cells (CD19), macrophages (CD68) and active caspase-3 and western blot (WB) analysis. CD19 (A-C); CD68 (D-F) and active caspase-3 (G-I) of HUVEC-immunized (A, D, G); intrathymically HUVEC-injected and HUVEC-immunized (B, E, F); and pristane-treated 3 days prior to HUVEC-immunization (C, F, I) rat lung sections. Magnification x400. (J) Quantitative WB analysis of rat lung tissue homogenates for CD19, CD68 and active caspase-3. *p < 0.01 compared to control or immune tolerized rats.